IL308771A - Methods of inhibiting RAS - Google Patents

Methods of inhibiting RAS

Info

Publication number
IL308771A
IL308771A IL308771A IL30877123A IL308771A IL 308771 A IL308771 A IL 308771A IL 308771 A IL308771 A IL 308771A IL 30877123 A IL30877123 A IL 30877123A IL 308771 A IL308771 A IL 308771A
Authority
IL
Israel
Prior art keywords
methods
inhibiting ras
ras
inhibiting
Prior art date
Application number
IL308771A
Other languages
English (en)
Hebrew (he)
Inventor
Kyle Seamon
Original Assignee
Revolution Medicines Inc
Kyle Seamon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revolution Medicines Inc, Kyle Seamon filed Critical Revolution Medicines Inc
Publication of IL308771A publication Critical patent/IL308771A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL308771A 2021-05-25 2022-05-25 Methods of inhibiting RAS IL308771A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163192837P 2021-05-25 2021-05-25
PCT/US2022/030823 WO2022251292A1 (en) 2021-05-25 2022-05-25 Methods for inhibiting ras

Publications (1)

Publication Number Publication Date
IL308771A true IL308771A (en) 2024-01-01

Family

ID=82115695

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308771A IL308771A (en) 2021-05-25 2022-05-25 Methods of inhibiting RAS

Country Status (11)

Country Link
US (1) US20240277796A1 (https=)
EP (1) EP4346898A1 (https=)
JP (1) JP2024521774A (https=)
KR (1) KR20240026526A (https=)
CN (2) CN118557730A (https=)
AU (1) AU2022281343A1 (https=)
CA (1) CA3219533A1 (https=)
IL (1) IL308771A (https=)
MX (1) MX2023013912A (https=)
TW (1) TW202313631A (https=)
WO (1) WO2022251292A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202132316A (zh) 2019-11-04 2021-09-01 美商銳新醫藥公司 Ras抑制劑
CA3194067A1 (en) 2020-09-15 2022-03-24 Revolution Medicines, Inc. Ras inhibitors
KR20240017811A (ko) 2021-05-05 2024-02-08 레볼루션 메디슨즈, 인크. 암의 치료를 위한 ras 억제제
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
CN118922423A (zh) * 2022-01-10 2024-11-08 锐新医药公司 Ras抑制剂
JP2025519199A (ja) * 2022-06-01 2025-06-24 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト がんの治療のためのハロインドール大環状化合物
KR20250085767A (ko) 2022-09-29 2025-06-12 광조우 조요 파마테크 컴퍼니 리미티드 거대고리 유도체 및 이의 적용
CN120813588A (zh) 2023-02-14 2025-10-17 豪夫迈·罗氏有限公司 用于治疗癌症的三环化合物
AU2024241633A1 (en) * 2023-03-30 2025-11-06 Revolution Medicines, Inc. Compositions for inducing ras gtp hydrolysis and uses thereof
TW202446387A (zh) * 2023-04-06 2024-12-01 瑞士商赫孚孟拉羅股份公司 用於治療癌症之三環化合物
TW202508595A (zh) 2023-05-04 2025-03-01 美商銳新醫藥公司 用於ras相關疾病或病症之組合療法
US20250041295A1 (en) * 2023-07-14 2025-02-06 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2025162395A1 (zh) * 2024-02-01 2025-08-07 山东先声生物制药有限公司 吲哚衍生物作为ras抑制剂及其应用
CN119431325A (zh) * 2024-10-31 2025-02-14 诚达药业股份有限公司 一种3-(1h-吡唑-1-基)氮杂环丁烷类化合物及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021012057A2 (pt) 2018-12-21 2021-10-19 Revolution Medicines, Inc. Compostos que participam de ligação cooperativa e usos dos mesmos
DE102019122206B4 (de) 2019-08-19 2021-07-08 Webasto SE Dachmodul zur Bildung eines Fahrzeugdachs mit Umfeldsensor
TW202132316A (zh) 2019-11-04 2021-09-01 美商銳新醫藥公司 Ras抑制劑
IL322454A (en) 2019-11-04 2025-09-01 Revolution Medicines Inc ras inhibitors
AU2020377925A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
CA3194067A1 (en) 2020-09-15 2022-03-24 Revolution Medicines, Inc. Ras inhibitors

Also Published As

Publication number Publication date
KR20240026526A (ko) 2024-02-28
MX2023013912A (es) 2024-02-12
EP4346898A1 (en) 2024-04-10
CN117715658A (zh) 2024-03-15
US20240277796A1 (en) 2024-08-22
CA3219533A1 (en) 2022-12-01
CN118557730A (zh) 2024-08-30
WO2022251292A1 (en) 2022-12-01
AU2022281343A1 (en) 2023-11-30
TW202313631A (zh) 2023-04-01
JP2024521774A (ja) 2024-06-04

Similar Documents

Publication Publication Date Title
IL307396A (en) Methods for inhibiting RAS
IL308771A (en) Methods of inhibiting RAS
IL308193A (en) RAS inhibitors
IL292643B1 (en) ras inhibitors
GB202001344D0 (en) Ras Inhibitors
IL320513A (en) RAS inhibitors
IL292642B1 (en) RAS inhibitors
IL274540B (en) Compounds useful for cdk7 inhibition
IL268614A (en) Aminotriazolopyridines as kinase inhibitors
IL268430A (en) Methods for treating cancer using hsp90 inhibitors
IL276269A (en) Aminopyrrolotriazines as kinase inhibitors
IL274207B (en) Aminoimidazopyridazines as kinase inhibitors
IL281634A (en) Diacosocyclobutanylamino-3-hydroxy-picoline modified amide and its use as a CCR6 inhibitor
EP3636262A4 (en) AGENT FOR PREVENTING OR TREATING ALZHEIMER-LIKE DEMENTIA
IL256537A (en) Inhibitors for treating uveal melanoma
IL271967A (en) Methods for treating congenital hypersecretion of insulin
PT3589637T (pt) Compostos úteis para inibir ror-gamma-t
HK40109955A (en) Methods for inhibiting ras
HK40107246A (zh) 抑制ras的方法
HUE054483T2 (hu) ROR-gamma-T gátlására alkalmas vegyületek
GB201807845D0 (en) Kinase Inhibitors
IL313756A (en) Inhibitors of the sestrin-MAPK complex
HK40131521A (en) Ras inhibitors
EP4263533C0 (en) Erap inhibitors
HK40113167A (en) Ras inhibitors